Lenta , E. et al. 2022. Acute respiratory distress syndrome secondary to Sars-COV-2 infection: treatment with mesenchymal stromal cells (mscs) to prevent pulmonary complications. Journal of Advanced Health Care. 4, 2 (Apr. 2022). DOI:https://doi.org/10.36017/jahc202242196.